ArticleCell death & disease2026

Targeting SLC1A5-mediated glutamine metabolism overcomes PARP inhibitor resistance in ovarian cancer.

Fang Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.